abstract |
The invention relates to PPAR-alpha activating compounds of the general formula wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, A and X are as defined in the specification for treatment of, for example, coronary heart disease, and a process for their preparation. |